NFKB1 and amyotrophic lateral sclerosis: Yet, the protective effects of IMS-088 in a mouse model based on infusion of CSF from sporadic ALS patients suggest that the NF-κB signaling pathway represents a compelling therapeutic target for sporadic ALS cases.